Title21 Health Solutions is moving the needle in Transforming Healthcare
The 10 Most Influential Leaders in Pharmaceutical, 2021
![](https://beyondexclamation.com/wp-content/uploads/2021/02/4.-Lynn-Fischer-CEO-Title21-Health-Solution.jpg)
The healthcare industry is now in the midst of the most
change its ever seen in its history. The
technology wave that has disrupted so many other industries has now descended
on healthcare. One such organization at the forefront and leading this change
is Title21 Health Solutions. Title21 has risen to a leadership position in the
immunotherapy, regenerative, and cell and gene therapy domains with their
flexible, end-to-end integrated software platform. Lynn Fischer, CEO of Title21
Health Solutions, has some interesting insights to share from their successful
journey.
About Title21 Health Solutions
For nearly 20 years, Title21 has been providing easy-to-use,
HIPAA-compliant software solutions targeting the FDA-regulated domains. Having
started with a suite of quality management solutions for the blood industry,
Title21 pivoted into the Cellular Therapy market and has invested extensively to
develop a leading platform targeting both academic and cGMP manufacturing
programs. These market segments are
demanding as they each require highly flexible solutions to accommodate their
complex and unique workflows. The Title21 system allow laboratory, clinical,
and manufacturing entities to be relieved of the many of the paperwork burdens normally
found in complex biologic processing, allowing them focus on higher-value work,
serving more patients with better safety, quality and efficiency. Programs that
implement Title21’s solutions find they can take products from bench to bedside
with less resources and higher throughput than ever before.
The Right Mix of Solutions
Title21’s product roadmap has been largely driven by their
customers and their need to meet cGMP\cGLP requirements. In addition to
supporting core Cell and Gene Manufacturing processes such as Lab Processing,
Collections, Reagent Manufacturing, CAR- T workflows, Chain of Custody/Identity
and Product Inventory, Title21 also offers a complete Enterprise Quality Management
system that includes Document Control, Error Management and Learning and
Competency Management, Audit, Corrective and Preventive Action, Supplies,
Equipment Maintenance and Calibration. Title21 enables manufacturing and healthcare
teams to have patient, manufacturing and quality data accessible in one system.
With out-of-the-box integrated modules, Title21 eliminates double-data entry,
validates data and provides quick access to any Batch record. Title21’s comprehensive
interoperability capabilities allow for data sharing with external systems like
EPIC, Cerner, SAP and others to provide seamless data flow across complex and
disparate systems.
The Driving Factor
Title21 is aligned to the same drivers
as their customers; serving patients to the very best of their abilities. With
customer relationships built on this shared foundation of placing patient care
first, Title21 has developed many long-standing and strategic partnerships that
bring safety and innovation to the forefront. This approach has positioned
Title21 in the marketplace as a “go-to” solution for hospitals, Cell and Gene Therapy
Laboratories, and cGMP manufacturing facilities.
The Road Ahead
Title21’s mission is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments. Every team member at Title21 is dedicated to supporting the lifesaving work of these institutions and helping them deliver on the promise of a new generation of curative therapies.